[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Eosinophilic Esophagitis Drug Market Report 2018

January 2018 | 98 pages | ID: U9D13CF7EA2EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Eosinophilic Esophagitis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Eosinophilic Esophagitis Drug in these regions, from 2013 to 2025 (forecast).
United States Eosinophilic Esophagitis Drug market competition by top manufacturers/players, with Eosinophilic Esophagitis Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Adare Pharmaceuticals Inc
  • Calypso Biotech SA
  • Celgene Corp
  • DBV Technologies SA
  • Dr. Falk Pharma GmbH
  • Quorum Innovations LLC
  • Regeneron Pharmaceuticals Inc
  • Shire Plc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • RPC-4046
  • Budesonide
  • Qi-201
  • CALY-002
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Eosinophilic Esophagitis Drug Market Report 2018

1 EOSINOPHILIC ESOPHAGITIS DRUG OVERVIEW

1.1 Product Overview and Scope of Eosinophilic Esophagitis Drug
1.2 Classification of Eosinophilic Esophagitis Drug by Product Category
  1.2.1 United States Eosinophilic Esophagitis Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Eosinophilic Esophagitis Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 RPC-4046
  1.2.4 Budesonide
  1.2.5 Qi-201
  1.2.6 CALY-002
  1.2.7 Others
1.3 United States Eosinophilic Esophagitis Drug Market by Application/End Users
  1.3.1 United States Eosinophilic Esophagitis Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Eosinophilic Esophagitis Drug Market by Region
  1.4.1 United States Eosinophilic Esophagitis Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.5 New England Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.6 The South Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Eosinophilic Esophagitis Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Eosinophilic Esophagitis Drug (2013-2025)
  1.5.1 United States Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Eosinophilic Esophagitis Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES EOSINOPHILIC ESOPHAGITIS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Eosinophilic Esophagitis Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Eosinophilic Esophagitis Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Eosinophilic Esophagitis Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Eosinophilic Esophagitis Drug Market Competitive Situation and Trends
  2.4.1 United States Eosinophilic Esophagitis Drug Market Concentration Rate
  2.4.2 United States Eosinophilic Esophagitis Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES EOSINOPHILIC ESOPHAGITIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Eosinophilic Esophagitis Drug Sales and Market Share by Region (2013-2018)
3.2 United States Eosinophilic Esophagitis Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Eosinophilic Esophagitis Drug Price by Region (2013-2018)

4 UNITED STATES EOSINOPHILIC ESOPHAGITIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Eosinophilic Esophagitis Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Eosinophilic Esophagitis Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Eosinophilic Esophagitis Drug Price by Type (2013-2018)
4.4 United States Eosinophilic Esophagitis Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES EOSINOPHILIC ESOPHAGITIS DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Eosinophilic Esophagitis Drug Sales and Market Share by Application (2013-2018)
5.2 United States Eosinophilic Esophagitis Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES EOSINOPHILIC ESOPHAGITIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Adare Pharmaceuticals Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Eosinophilic Esophagitis Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Calypso Biotech SA
  6.2.2 Eosinophilic Esophagitis Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Calypso Biotech SA Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Celgene Corp
  6.3.2 Eosinophilic Esophagitis Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Celgene Corp Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 DBV Technologies SA
  6.4.2 Eosinophilic Esophagitis Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 DBV Technologies SA Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Dr. Falk Pharma GmbH
  6.5.2 Eosinophilic Esophagitis Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Quorum Innovations LLC
  6.6.2 Eosinophilic Esophagitis Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Quorum Innovations LLC Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Regeneron Pharmaceuticals Inc
  6.7.2 Eosinophilic Esophagitis Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Shire Plc
  6.8.2 Eosinophilic Esophagitis Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shire Plc Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 EOSINOPHILIC ESOPHAGITIS DRUG MANUFACTURING COST ANALYSIS

7.1 Eosinophilic Esophagitis Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Eosinophilic Esophagitis Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Eosinophilic Esophagitis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Eosinophilic Esophagitis Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES EOSINOPHILIC ESOPHAGITIS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Eosinophilic Esophagitis Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Eosinophilic Esophagitis Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Eosinophilic Esophagitis Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Eosinophilic Esophagitis Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Eosinophilic Esophagitis Drug
Figure United States Eosinophilic Esophagitis Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Eosinophilic Esophagitis Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure RPC-4046 Product Picture
Figure Budesonide Product Picture
Figure Qi-201 Product Picture
Figure CALY-002 Product Picture
Figure Others Product Picture
Figure United States Eosinophilic Esophagitis Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Eosinophilic Esophagitis Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Eosinophilic Esophagitis Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Eosinophilic Esophagitis Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Eosinophilic Esophagitis Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Eosinophilic Esophagitis Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Eosinophilic Esophagitis Drug Sales Share by Players/Suppliers
Figure 2017 United States Eosinophilic Esophagitis Drug Sales Share by Players/Suppliers
Figure United States Eosinophilic Esophagitis Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Eosinophilic Esophagitis Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Eosinophilic Esophagitis Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Eosinophilic Esophagitis Drug Revenue Share by Players/Suppliers
Figure 2017 United States Eosinophilic Esophagitis Drug Revenue Share by Players/Suppliers
Table United States Market Eosinophilic Esophagitis Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Eosinophilic Esophagitis Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Eosinophilic Esophagitis Drug Market Share of Top 3 Players/Suppliers
Figure United States Eosinophilic Esophagitis Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Eosinophilic Esophagitis Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Eosinophilic Esophagitis Drug Product Category
Table United States Eosinophilic Esophagitis Drug Sales (K Pcs) by Region (2013-2018)
Table United States Eosinophilic Esophagitis Drug Sales Share by Region (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Sales Share by Region (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Sales Market Share by Region in 2017
Table United States Eosinophilic Esophagitis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Eosinophilic Esophagitis Drug Revenue Share by Region (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Revenue Market Share by Region (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Revenue Market Share by Region in 2017
Table United States Eosinophilic Esophagitis Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Eosinophilic Esophagitis Drug Sales (K Pcs) by Type (2013-2018)
Table United States Eosinophilic Esophagitis Drug Sales Share by Type (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Sales Share by Type (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Sales Market Share by Type in 2017
Table United States Eosinophilic Esophagitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Eosinophilic Esophagitis Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Eosinophilic Esophagitis Drug by Type (2013-2018)
Figure Revenue Market Share of Eosinophilic Esophagitis Drug by Type in 2017
Table United States Eosinophilic Esophagitis Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Sales Growth Rate by Type (2013-2018)
Table United States Eosinophilic Esophagitis Drug Sales (K Pcs) by Application (2013-2018)
Table United States Eosinophilic Esophagitis Drug Sales Market Share by Application (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Sales Market Share by Application (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Sales Market Share by Application in 2017
Table United States Eosinophilic Esophagitis Drug Sales Growth Rate by Application (2013-2018)
Figure United States Eosinophilic Esophagitis Drug Sales Growth Rate by Application (2013-2018)
Table Adare Pharmaceuticals Inc Basic Information List
Table Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales Growth Rate (2013-2018)
Figure Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales Market Share in United States (2013-2018)
Figure Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Revenue Market Share in United States (2013-2018)
Table Calypso Biotech SA Basic Information List
Table Calypso Biotech SA Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Calypso Biotech SA Eosinophilic Esophagitis Drug Sales Growth Rate (2013-2018)
Figure Calypso Biotech SA Eosinophilic Esophagitis Drug Sales Market Share in United States (2013-2018)
Figure Calypso Biotech SA Eosinophilic Esophagitis Drug Revenue Market Share in United States (2013-2018)
Table Celgene Corp Basic Information List
Table Celgene Corp Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Celgene Corp Eosinophilic Esophagitis Drug Sales Growth Rate (2013-2018)
Figure Celgene Corp Eosinophilic Esophagitis Drug Sales Market Share in United States (2013-2018)
Figure Celgene Corp Eosinophilic Esophagitis Drug Revenue Market Share in United States (2013-2018)
Table DBV Technologies SA Basic Information List
Table DBV Technologies SA Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure DBV Technologies SA Eosinophilic Esophagitis Drug Sales Growth Rate (2013-2018)
Figure DBV Technologies SA Eosinophilic Esophagitis Drug Sales Market Share in United States (2013-2018)
Figure DBV Technologies SA Eosinophilic Esophagitis Drug Revenue Market Share in United States (2013-2018)
Table Dr. Falk Pharma GmbH Basic Information List
Table Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Sales Growth Rate (2013-2018)
Figure Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Sales Market Share in United States (2013-2018)
Figure Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Revenue Market Share in United States (2013-2018)
Table Quorum Innovations LLC Basic Information List
Table Quorum Innovations LLC Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Quorum Innovations LLC Eosinophilic Esophagitis Drug Sales Growth Rate (2013-2018)
Figure Quorum Innovations LLC Eosinophilic Esophagitis Drug Sales Market Share in United States (2013-2018)
Figure Quorum Innovations LLC Eosinophilic Esophagitis Drug Revenue Market Share in United States (2013-2018)
Table Regeneron Pharmaceuticals Inc Basic Information List
Table Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales Growth Rate (2013-2018)
Figure Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales Market Share in United States (2013-2018)
Figure Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Revenue Market Share in United States (2013-2018)
Table Shire Plc Basic Information List
Table Shire Plc Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Shire Plc Eosinophilic Esophagitis Drug Sales Growth Rate (2013-2018)
Figure Shire Plc Eosinophilic Esophagitis Drug Sales Market Share in United States (2013-2018)
Figure Shire Plc Eosinophilic Esophagitis Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Eosinophilic Esophagitis Drug
Figure Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
Figure Eosinophilic Esophagitis Drug Industrial Chain Analysis
Table Raw Materials Sources of Eosinophilic Esophagitis Drug Major Players/Suppliers in 2017
Table Major Buyers of Eosinophilic Esophagitis Drug
Table Distributors/Traders List
Figure United States Eosinophilic Esophagitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Eosinophilic Esophagitis Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Eosinophilic Esophagitis Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Eosinophilic Esophagitis Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Eosinophilic Esophagitis Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Eosinophilic Esophagitis Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Eosinophilic Esophagitis Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Eosinophilic Esophagitis Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Eosinophilic Esophagitis Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Eosinophilic Esophagitis Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Eosinophilic Esophagitis Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Eosinophilic Esophagitis Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories